These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34168190)

  • 21. The use of ¹⁸F-BCPP-EF as a PET probe for complex I activity in the brain.
    Tsukada H
    Methods Enzymol; 2014; 547():417-31. PubMed ID: 25416368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis.
    Tavakoli S; Zamora D; Ullevig S; Asmis R
    J Nucl Med; 2013 Sep; 54(9):1661-7. PubMed ID: 23886729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain:
    Mansur A; Rabiner EA; Comley RA; Lewis Y; Middleton LT; Huiban M; Passchier J; Tsukada H; Gunn RN;
    J Nucl Med; 2020 Jan; 61(1):96-103. PubMed ID: 31324712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[
    Boyle AJ; Murrell E; Tong J; Schifani C; Narvaez A; Wuest M; West F; Wuest F; Vasdev N
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases.
    Xiang X; Wind K; Wiedemann T; Blume T; Shi Y; Briel N; Beyer L; Biechele G; Eckenweber F; Zatcepin A; Lammich S; Ribicic S; Tahirovic S; Willem M; Deussing M; Palleis C; Rauchmann BS; Gildehaus FJ; Lindner S; Spitz C; Franzmeier N; Baumann K; Rominger A; Bartenstein P; Ziegler S; Drzezga A; Respondek G; Buerger K; Perneczky R; Levin J; Höglinger GU; Herms J; Haass C; Brendel M
    Sci Transl Med; 2021 Oct; 13(615):eabe5640. PubMed ID: 34644146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
    Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined [(18)F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice.
    Israel I; Ohsiek A; Al-Momani E; Albert-Weissenberger C; Stetter C; Mencl S; Buck AK; Kleinschnitz C; Samnick S; Sirén AL
    J Neuroinflammation; 2016 Jun; 13(1):140. PubMed ID: 27266706
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Mitchell KG; Amini B; Wang Y; Carter BW; Godoy MCB; Parra ER; Behrens C; Villalobos P; Reuben A; Lee JJ; Weissferdt A; Moran CA; Fujimoto J; Sepesi B; Walsh GL; Vaporciyan AA; Hofstetter WL; William WN; Gibbons DL; Wang J; Hwu P; Swisher SG; Piwnica-Worms D; Kadara H; Wistuba II; Heymach JV; Peng W; Cascone T
    Cancer Immunol Immunother; 2020 Aug; 69(8):1519-1534. PubMed ID: 32300858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-6-phosphatase Expression-Mediated [
    Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK
    Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
    Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY
    Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Ikegaya S; Kakiuchi T; Ohba H; Nishiyama S; Fukomoto D; Kanazawa M; Harada N; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2021 Dec; 18(1):288. PubMed ID: 34893067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocarboxylate transporter 1 promotes classical microglial activation and pro-inflammatory effect via 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3.
    Kong L; Wang Z; Liang X; Wang Y; Gao L; Ma C
    J Neuroinflammation; 2019 Nov; 16(1):240. PubMed ID: 31779643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis.
    Wang L; Pavlou S; Du X; Bhuckory M; Xu H; Chen M
    Mol Neurodegener; 2019 Jan; 14(1):2. PubMed ID: 30634998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
    van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
    J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of UCP2 impairs cold-induced non-shivering thermogenesis by promoting a shift toward glucose utilization in brown adipose tissue.
    Caron A; Labbé SM; Carter S; Roy MC; Lecomte R; Ricquier D; Picard F; Richard D
    Biochimie; 2017 Mar; 134():118-126. PubMed ID: 28130074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined hyperpolarized
    Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
    Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [
    de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
    Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCPP compounds, PET probes for early therapeutic evaluations, specifically bind to mitochondrial complex I.
    Kazami S; Nishiyama S; Kimura Y; Itoh H; Tsukada H
    Mitochondrion; 2019 May; 46():97-102. PubMed ID: 29563046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis.
    Leiter I; Bascuñana P; Bengel FM; Bankstahl JP; Bankstahl M
    Neurobiol Dis; 2019 Oct; 130():104510. PubMed ID: 31212069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.